Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor (EGFR-TKI)
1 clinical trials · Condition
◉ Watch Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor (EGFR-TKI)
| Record | Firm | Date |
|---|---|---|
| RT Plus EGFR-TKI for Wild-type NSCLC (NCT02738983) | Hangzhou Cancer Hospital | 2012-01-01 |
Track Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor (EGFR-TKI) automatically
Every clearance here is in the API, with alerts when new ones post.